Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation

Movement Disorders

Volumn 22, Issue 2, 2007, Pages 275-278

  Giordana, Maria Teresa ^a   D'Agostino, Carla ^a   Albani, Giovanni ^b   Mauro, Alessandro ^a,b   Di Fonzo, Alessio ^c,d   Antonini, Angelo ^e   Bonifati, Vincenzo ^c  

^a UNIVERSITY OF TURIN   (Italy)

^b ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF MILAN   (Italy)

^e PARKINSON INSTITUTE   (Italy)

Author keywords

Ile1371val mutation; LRRK2; Neuropathology; Parkinson's disease

Indexed keywords

ALPHA SYNUCLEIN; ISOLEUCINE; LEUCINE RICH REPEAT KINASE 2; LEVODOPA; UBIQUITIN; VALINE;

ADULT; AGED; ANAMNESIS; ARTICLE; BRAIN DEGENERATION; CASE REPORT; CLINICAL FEATURE; DIFFUSE LEWY BODY DISEASE; FEMALE; GENE MUTATION; GENETIC ASSOCIATION; HUMAN; NEUROPATHOLOGY; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA;

AGED; ALPHA-SYNUCLEIN; BRAIN; FATAL OUTCOME; FEMALE; HUMANS; LEWY BODIES; PARKINSON DISEASE; POINT MUTATION; PROTEIN-SERINE-THREONINE KINASES; SUBSTANTIA NIGRA; TAU PROTEINS;

EID: 33847750732     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.21281     Document Type: Article

References (22)

1. Zimprich A, Biskup S, Leitner P, et al. Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology. Neuron 2004;44:601-607.
2. Paisan-Ruiz C, Jain S, Evans EW, et al. Cloning of the gene containing mutations that cause PARK8-linked Parkinson's disease. Neuron 2004;44:595-600.
3. Gilks WP, Abou-Sleiman PM, Gandhi S, et al. A common LRRK2 mutation in idiopathic Parkinson's disease. Lancet 2005;365:415-416.
4. Goldwurm S, Di Fonzo A, Simons EJ, et al. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor. J Med Genet 2005;42:E65.
5. Zabetian CP, Samii A, Mosley AD, et al. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations. Neurology 2005;65:741-744.
6. Hasegawa K, Kowa H. Autosomal dominant familial Parkinson disease: older onset of age, and good response to levodopa therapy. Eur Neurol 1997;38(Suppl. 1):39-43.
7. Funayama M, Hasegawa K, Kowa H, Saito M, Tsuji S, Obata F. A new locus for Parkinson's disease (PARK8) maps to chromosome 12p11.2-q13.1. Ann Neurol 2002;51:296-301.
8. Wszolek ZK, Vieregge P, Uittis RJ, et al. German-Canadian family (Family A) with parkinsonism, amyotrophy and dementia: longitudinal observations. Parkinsonism Relat Disord 1997;3:125-139.
9. Wszolek ZK, Pfeiffer RF, Tsuboi Y, et al. Autosomal dominant parkinsonism associated with variable synuclein and tau pathology. Neurology 2004;62:1619-1622.
10. Khan NL, Jain S, Lynch JM, et al. Mutations in the gene LRRK2 encoding dardarin (PARK8) cause familial Parkinson's disease: clinical, pathological, olfactory and functional imaging and genetic data. Brain 2005;128(Pt. 12):2786-2796.
11. Giasson BI, Covy JP, Bonini NM, Hurtig HI, Farrer MJ, Trojanowski JQ, Van Deerlin VM. Biochemical and pathological characterization of Lrrk2. Ann Neurol 2006;59:315-322.
12. Ross OA, Toft M, Whittle AJ, et al. Lrrk2 and Lewy body disease. Ann Neurol 2006;59:388-393.
13. Paisan-Ruiz C, Lang AE, Kawarai T, et al. LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 2005;65:696-700.
14. Di Fonzo A, Tassorelli C, De Mari M, et al. Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease. Eur J Hum Genet 2006;14:322-331.
15. Dale GE, Probst A, Luthert P, Martin J, Anderton BH, Leigh PN. Relationships between Lewy bodies and pale bodies in Parkinson's disease. Acta Neuropathol (Berl) 1992;83:525-529.
16. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clincal and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996;47:1113-1124.
17. Bras JM, Guerreiro RJ, Ribeiro MH, et al. G2019S dardarin substitution is a common cause of Parkinson's disease in a Portuguese cohort. Mov Disord 2005;20:1653-1655.
18. Gaig C, Ezquerra M, Marti MJ, Munoz E, Valldeoriola F, Tolosa E. LRRK2 mutations in Spanish patients with Parkinson disease: frequency, clinical features, and incomplete penetrance. Arch Neurol 2006;63:377-382.
19. Infante J, Rodriguez E, Combarros O, et al. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease. Neurosci Lett 2005;395:224-226.
20. Di Fonzo A, Rohe CF, Ferreira J, et al. A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson's disease. Lancet 2005;365:412-415.
21. Lesage S, Durr A, Tazir M, et al. LRRK2 G2019S as a cause of Parkinson's disease in North African Arabs. N Engl J Med 2006;354:422-423.
22. Ozelius LJ, Senthil G, Saunders-Pullman R, et al. LRRK2 G2019S as a cause of Parkinson's disease in Ashkenazi Jews. N Engl J Med 2006;354:424-425.